6-157084796-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001374828.1(ARID1B):​c.2382G>A​(p.Ala794Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.518 in 1,613,790 control chromosomes in the GnomAD database, including 219,781 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17741 hom., cov: 31)
Exomes 𝑓: 0.52 ( 202040 hom. )

Consequence

ARID1B
NM_001374828.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.618

Publications

23 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 6-157084796-G-A is Benign according to our data. Variant chr6-157084796-G-A is described in ClinVar as Benign. ClinVar VariationId is 126320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.618 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.566 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.2382G>A p.Ala794Ala synonymous_variant Exon 5 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.2382G>A p.Ala794Ala synonymous_variant Exon 5 of 20 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.473
AC:
71824
AN:
151786
Hom.:
17738
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.340
Gnomad AMI
AF:
0.683
Gnomad AMR
AF:
0.558
Gnomad ASJ
AF:
0.589
Gnomad EAS
AF:
0.553
Gnomad SAS
AF:
0.585
Gnomad FIN
AF:
0.386
Gnomad MID
AF:
0.602
Gnomad NFE
AF:
0.525
Gnomad OTH
AF:
0.499
GnomAD2 exomes
AF:
0.523
AC:
131459
AN:
251256
AF XY:
0.527
show subpopulations
Gnomad AFR exome
AF:
0.328
Gnomad AMR exome
AF:
0.610
Gnomad ASJ exome
AF:
0.608
Gnomad EAS exome
AF:
0.550
Gnomad FIN exome
AF:
0.389
Gnomad NFE exome
AF:
0.527
Gnomad OTH exome
AF:
0.521
GnomAD4 exome
AF:
0.523
AC:
764659
AN:
1461886
Hom.:
202040
Cov.:
80
AF XY:
0.525
AC XY:
381655
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.333
AC:
11165
AN:
33480
American (AMR)
AF:
0.603
AC:
26986
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.606
AC:
15845
AN:
26136
East Asian (EAS)
AF:
0.571
AC:
22668
AN:
39698
South Asian (SAS)
AF:
0.571
AC:
49228
AN:
86258
European-Finnish (FIN)
AF:
0.392
AC:
20942
AN:
53420
Middle Eastern (MID)
AF:
0.549
AC:
3168
AN:
5768
European-Non Finnish (NFE)
AF:
0.524
AC:
583242
AN:
1112006
Other (OTH)
AF:
0.520
AC:
31415
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
24334
48668
73002
97336
121670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16732
33464
50196
66928
83660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.473
AC:
71858
AN:
151904
Hom.:
17741
Cov.:
31
AF XY:
0.472
AC XY:
35011
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.340
AC:
14086
AN:
41420
American (AMR)
AF:
0.558
AC:
8533
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.589
AC:
2045
AN:
3472
East Asian (EAS)
AF:
0.553
AC:
2844
AN:
5144
South Asian (SAS)
AF:
0.584
AC:
2802
AN:
4794
European-Finnish (FIN)
AF:
0.386
AC:
4074
AN:
10550
Middle Eastern (MID)
AF:
0.610
AC:
178
AN:
292
European-Non Finnish (NFE)
AF:
0.524
AC:
35625
AN:
67924
Other (OTH)
AF:
0.499
AC:
1051
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1882
3764
5646
7528
9410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.517
Hom.:
82707
Bravo
AF:
0.479
Asia WGS
AF:
0.526
AC:
1831
AN:
3478
EpiCase
AF:
0.539
EpiControl
AF:
0.541

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 25, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 13, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Coffin-Siris syndrome 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.60
DANN
Benign
0.62
PhyloP100
-0.62
PromoterAI
-0.012
Neutral
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3734441; hg19: chr6-157405930; COSMIC: COSV51659621; API